Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Grade

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|May 21, 2022
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapyGeorg Emons, Noam Auslander, Peter Jo, et al.
Clinical Epigenetics|January 9, 2019
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsivenessVijayalakshmi Kari, Sanjay Kumar Raul, Jana Maria Henck, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
EMBO Reports|August 1, 2022
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repairOguz Bolgi, Maria Silva-Garcia, Breyan Ross, et al.
Scientific Reports|February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trialJochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
Nature Methods|June 9, 2025
Author Correction: Segment Anything for MicroscopyAnwai Archit, Luca Freckmann, Sushmita Nair, et al.
Nature Methods|February 12, 2025
Segment Anything for MicroscopyAnwai Archit, Luca Freckmann, Sushmita Nair, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 24, 2026
Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancerMaximilian Hellkamp, Simon Gertken, Jonas Buchloh, et al.
Cellular and Molecular Life Sciences : CMLS|December 19, 2022
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancerChristian Schneeweis, Sandra Diersch, Zonera Hassan, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|May 21, 2022
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapyGeorg Emons, Noam Auslander, Peter Jo, et al.
Clinical Epigenetics|January 9, 2019
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsivenessVijayalakshmi Kari, Sanjay Kumar Raul, Jana Maria Henck, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
EMBO Reports|August 1, 2022
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repairOguz Bolgi, Maria Silva-Garcia, Breyan Ross, et al.
Scientific Reports|February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trialJochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
Nature Methods|June 9, 2025
Author Correction: Segment Anything for MicroscopyAnwai Archit, Luca Freckmann, Sushmita Nair, et al.
Nature Methods|February 12, 2025
Segment Anything for MicroscopyAnwai Archit, Luca Freckmann, Sushmita Nair, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 24, 2026
Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancerMaximilian Hellkamp, Simon Gertken, Jonas Buchloh, et al.
Cellular and Molecular Life Sciences : CMLS|December 19, 2022
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancerChristian Schneeweis, Sandra Diersch, Zonera Hassan, et al.
Pageof 9